MedPath

Crestal Bone Loss in Mandibular Telescopic Overdentures. Overdenture with Milled Titanium, Milled Poly-ether Ketone Ketones and 3D Printed Chrome Cobalt Secondary Copings.

Early Phase 1
Completed
Conditions
Telescopic Overdentures
Dental Implants
Customized Abutments
Registration Number
NCT06639893
Lead Sponsor
Cairo University
Brief Summary

The objective of this clinical trial is to evaluate crestal bone loss every three months at time of overdenture insertion, 3, 6, 9, 12 months from overdenture use. Also, to evaluate prosthesis satisfaction.

All participants will receive conventional complete dentures, followed by two intraforaminal implants. After healing time, fabrication of secondary copings in all cases according to randomized groups for final overdenture insertion.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Sufficient remaining bone in height, width and thickness in the interforaminal area to allow installation of at least 3.3 mm diameter and 8 mm length implants.
  2. Adequate amount of interarch space of at least 12mm.
  3. Age range from 55 to 75 years old age.
Exclusion Criteria
  1. Systemic and metabolic diseases that may affect osseointegration.
  2. Patients receiving bisphosphonates therapy.
  3. Patients under radiotherapy or chemotherapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Crestal bone loss.one year

The aim of this study was to evaluate crestal peri implant bone loss in mandibular telescopic implant retained overdenture with milled titanium, milled poly-ether ketone ketones and 3D printed chrome cobalt secondary copings. Crestal bone loss evaluated every three months using standardized digital periapical radiograph at time of overdenture insertion, 3, 6, 9, and after 12 months from overdenture use.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

EL Minia University

🇪🇬

El minia, Egypt

© Copyright 2025. All Rights Reserved by MedPath